ArticleScientific reports2025
The emergency department quality improvement program improves the prognosis of patients with stroke in Taiwan: A nationwide cohort study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
In 2012, Taiwan implemented the Emergency Department Quality Improvement Program (EDQIP) to enhance the quality of care for patients with acute ischemic stroke (AIS). This retrospective study evaluated the program's effectiveness using data from the National Health Insurance Research Database. AIS patients were classified into three groups: a pre-implementation group (2011), and a post-implementation group (2013-2015), which was further subdivided into EDQIP and non-EDQIP groups based on hospital participation and receipt of performance-based incentives. Among 169,434 AIS cases identified between 2013 and 2015, 64,574 patients met the inclusion criteria. Compared to the non-EDQIP group, patients in the EDQIP group demonstrated a 9% absolute reduction in the 30-day mortality rate (6% vs. 15%; adjusted hazard ratio [aHR] = 0.40, 95% confidence interval [CI] = 0.32-0.50) and a 2% absolute reduction in the 72-hour emergency department revisits rate (5% vs. 7%). Additionally, the EDQIP group showed a 9% absolute reduction in 30-day mortality rate compared to the pre-EDQIP group (6% vs. 15%; aHR = 0.39, 95% CI = 0.31-0.49). These findings suggest that the EDQIP may be associated with improved clinical outcomes for AIS patients in Taiwan and may serve as a model for similar quality improvement initiatives worldwide.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.